# Research and Markets: Practical Biostatistics

Research and Markets (http://www.researchandmarkets.com/research/9xx9v9/practical) has announced the addition of Elsevier Science and Technology's new book "Practical Biostatistics" to their offering.

Evidence-based medicine aims to apply the best available evidence gained from the scientific method to medical decision making. It is a practice that uses statistical analysis of scientific methods and outcomes to drive further experimentation and diagnosis. The profusion of evidence-based medicine in medical practice and clinical research has produced a need for life scientists and clinical researchers to assimilate biostatistics into their work to meet efficacy and practical standards. Practical Biostatistics provides researchers, medical professionals, and students with a friendly, practical guide to biostatistics. With a detailed outline of implementation steps complemented by a review of important topics, this book can be used as a quick reference or a hands-on guide to effectively incorporate biostatistics in clinical trials.

Key Features:

- Customized presentation for biological investigators with examples taken from current clinical trials in multiple disciplines

- Clear and concise definitions and examples provide a pragmatic guide to bring clarity to the applications of statistics in improving human health

- Addresses the challenge of assimilation of mathematical concepts to better interpret literature, to build stronger studies, to present research effectively, and to improve communication with supporting biostatisticians

Topics Covered:

PART 1

STUDY TYPE DETERMINATION

1. Epidemiological studies

2. Analytical studies

3. Summary

PART 2

OBSERVATIONAL STUDIES

4. Determination of association strength between an exposure factor and an event in observational studies

5. Increasing accuracy in observational studies

PART 3

STEP-BY-STEP BIOSTATISTICS OF A CLINICAL TRIAL

6. STEP 1: Investigator's hypothesis and expression of its corresponding outcome

7. STEP 2: n estimation and n assessment of a published trial

8. STEP 3: Organization of variables and endpoints

9. STEP 4: Measures for results expression of a clinical trial

10. STEP 5: Determination of normality or non-normality of data distribution

11. STEP 6: Hypothesis testing

12. STEP 7: Correlating sample data with the general population 95% confidence Interval

PART 4

13. Individual and collective benefit and risk indexes inferable from intervention cohort studies

14. Statistical assessment of diagnostic tests for the clinic

15. Systematic reviews and meta-analyses

16. Correlation and regression

17. Per protocol analysis and intention to treat analysis

Self-evaluation Annotated answers Microsoft Excel 2010

Basics References

Glossary

Index

Authors

Suchmacher, Mendel

Geller, Mauro

Source: Elsevier Science and Technology

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology, Mathematics

View Comments and Join the Discussion!

 1 IONS, LLNW: 18 Stocks Moving In Friday's Pre-Market Session 2 AAPL: Morgan Stanley Explains Why Apple Investors Need To Be 'Cauti... 3 NNA, PAA: Benzinga's Top Upgrades, Downgrades For April 20, 2018 4 XXII, IGC: Pot Stocks, ETFs And Top News From The Cannabis I... 5 CAG, BIIB: Benzinga Pro's 5 Stocks To Watch Today 6 AMZN: Credit Suisse Raises Amazon Price Ta... 7 PF, CAG: Some Perspective On A Possibl...
 1 RHHBY, ARPO: HC Wainwright Says Aerpio Pharma Flies Under The Radar Due To OTC Lis... 2 FB, AAPL: Barron's Picks And Pans: General Electric, General Mills... 3 RHP, JPM: Benzinga's Insider Buys Of The Week: JPMorgan, S... 4 GUSH, DRIP: A Leveraged ETF On The Cusp Of Something Big 5 GBTC: Today In Cryptocurrency: European Regul... 6 TWX, T: Telecom Stocks Fall Amid Report O... 7 CNTTF, MCD: Pot Stocks, ETFs And To...